110 related articles for article (PubMed ID: 21355306)
1. [The effect of C3a, C5a and their receptor antagonists on the expression of beta-catenin in renal tubular cells].
Liu F; Gou R; Huang J; Fu P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):74-7. PubMed ID: 21355306
[TBL] [Abstract][Full Text] [Related]
2. Effect of anaphylatoxin C3a, C5a on the tubular epithelial-myofibroblast transdifferentiation in vitro.
Liu F; Gou R; Huang J; Fu P; Chen F; Fan WX; Huang YQ; Zang L; Wu M; Qiu HY; Wei DP
Chin Med J (Engl); 2011 Dec; 124(23):4039-45. PubMed ID: 22340339
[TBL] [Abstract][Full Text] [Related]
3. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
4. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
[TBL] [Abstract][Full Text] [Related]
5. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.
Proctor LM; Arumugam TV; Shiels I; Reid RC; Fairlie DP; Taylor SM
Br J Pharmacol; 2004 Jun; 142(4):756-64. PubMed ID: 15159277
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
7. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
[TBL] [Abstract][Full Text] [Related]
8. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
10. Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage.
Garrett MC; Otten ML; Starke RM; Komotar RJ; Magotti P; Lambris JD; Rynkowski MA; Connolly ES
Brain Res; 2009 Nov; 1298():171-7. PubMed ID: 19410563
[TBL] [Abstract][Full Text] [Related]
11. Complement factors C3a and C5a have distinct hemodynamic effects in the rat.
Proctor LM; Moore TA; Monk PN; Sanderson SD; Taylor SM; Woodruff TM
Int Immunopharmacol; 2009 Jun; 9(6):800-6. PubMed ID: 19285573
[TBL] [Abstract][Full Text] [Related]
12. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.
Fukuoka Y; Ember JA; Hugli TE
Biochem Biophys Res Commun; 1998 Jan; 242(3):663-8. PubMed ID: 9464274
[TBL] [Abstract][Full Text] [Related]
14. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
[TBL] [Abstract][Full Text] [Related]
15. [Study on effect of fushenkeli on expression of TAK1 in human renal tubular epithelial cells and its possible mechanism].
Liu M; Zeng Y; Lu S; Li J; Liu T
Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(18):2571-5. PubMed ID: 22256769
[TBL] [Abstract][Full Text] [Related]
16. [Alisol B inhibited complement 3a-induced human renal tubular epithelial to mesenchymal transition].
Zhang RF; Wan JX; Xu YF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Oct; 32(10):1407-12. PubMed ID: 23163157
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats.
Lillegard KE; Loeks-Johnson AC; Opacich JW; Peterson JM; Bauer AJ; Elmquist BJ; Regal RR; Gilbert JS; Regal JF
J Pharmacol Exp Ther; 2014 Nov; 351(2):344-51. PubMed ID: 25150279
[TBL] [Abstract][Full Text] [Related]
18. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
19. C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway.
Li L; Yin Q; Tang X; Bai L; Zhang J; Gou S; Zhu H; Cheng J; Fu P; Liu F
PLoS One; 2014; 9(11):e113639. PubMed ID: 25422985
[TBL] [Abstract][Full Text] [Related]
20. Complement activation sustains neuroinflammation and deteriorates adult neurogenesis and spatial memory impairment in rat hippocampus following sleep deprivation.
Wadhwa M; Prabhakar A; Anand JP; Ray K; Prasad D; Kumar B; Panjwani U
Brain Behav Immun; 2019 Nov; 82():129-144. PubMed ID: 31408672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
